G Mark Foletta

Affiliations

  • Director at Dexcom Inc (DXCM), 2021-10-05
  • Director at Amn Healthcare Services Inc (AMN), 2021-06-15
  • Director at Enanta Pharmaceuticals Inc (ENTA), 2021-03-04
  • Evp & Chief Financial Officer at Tocagen Inc (TOCA), 2019-10-05
  • Director at Regulus Therapeutics Inc. (RGLS), 2017-12-07
  • Interim Cfo at Biocept Inc (BIOC), 2015-09-02
  • Director at Ambit Biosciences Corp (AMBI), 2014-11-12
  • Svp, Chief Financial Officer at Amylin Pharmaceuticals Inc (AMLN), 2012-08-10
  • Director at Anadys Pharmaceuticals Inc (ANDS), 2011-05-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TOCA $4.30 5,000 Officer 15,042 2019-05-28 Filing
TOCA $10.00 5,000 Officer 5,000 2017-04-19 Filing
RGLS $7.64 10,000 Director 10,000 2015-08-13 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DXCM $551.58 1 Director 13,597 2021-10-01 Filing
DXCM $547.06 51 Director 13,598 2021-10-01 Filing
DXCM $544.39 181 Director 13,649 2021-10-01 Filing
DXCM $543.15 126 Director 13,830 2021-10-01 Filing
DXCM $540.93 88 Director 13,956 2021-10-01 Filing